Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Montfort K. Van"'
Autor:
Preijers, F.W.M.B., Velden, V.H.J. van der, Preijers, T., Brooimans, R.A., Marijt, E., Homburg, C., Montfort, K. van, Gratama, J.W., Sect Immunological Molecular Cell
Publikováno v:
Cytometry Part B: Clinical Cytometry, 90(3), 267-278
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::32fbc9062e70d8e22d7cdf40a4e46de3
https://hdl.handle.net/1887/113938
https://hdl.handle.net/1887/113938
Autor:
Preijers, F.W.M.B., Velden, V.H. van der, Preijers, T., Brooimans, R.A., Marijt, E., Homburg, C., Montfort, K. van, Gratama, J.W.
Publikováno v:
Cytometry. Part B-Clinical Cytometry, 2016, pp. 267-278
Cytometry. Part B-Clinical Cytometry, 2016, 267-278
Cytometry. Part B-Clinical Cytometry, 2016, 267-278
Item does not contain fulltext
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::edad9205bf550b8d602f78ba0779b462
https://hdl.handle.net/2066/168496
https://hdl.handle.net/2066/168496
Autor:
M.J. Hooning, Curt W. Burger, Caroline Seynaeve, A. Heemskerk-Gerritsen, Montfort K Van, A. Jager, Margriet Collée, Marian B. E. Menke-Pluymers, Doorn L Van, P. M. L. H. Vencken, Mieke Kriege
Publikováno v:
Cancer Research. 71:P4-11
Background In view of the increased risk of developing breast (BC) cancer, BRCA mutation carriers are offered intensive surveillance or risk reducing mastectomy (RRM) and/or salpingo-ovariectomy (RRSO). It is insufficiently clear how to counsel mutat
Autor:
Montfort K. Van
Publikováno v:
Value in Health. 17(7)
Autor:
Alonso, A., Molenberghs, G., van Breukelen, G.J.P., Montfort, K. van, Oud, J., Wendimagegn, G.
Publikováno v:
Developments in Statistical Evaluation of Clinical Trials, 227-246
STARTPAGE=227;ENDPAGE=246;TITLE=Developments in Statistical Evaluation of Clinical Trials
Developments in Statistical Evaluation of Clinical Trials ISBN: 9783642553448
STARTPAGE=227;ENDPAGE=246;TITLE=Developments in Statistical Evaluation of Clinical Trials
Developments in Statistical Evaluation of Clinical Trials ISBN: 9783642553448
The increasing cost of drug development has raised the demand on the use of biomarkers as surrogate endpoints for the evaluation of new drugs in clinical trials. However, failed past attempts to use surrogate endpoints made it clear that, before deci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2e127cc7f09397b1824d9c45d6cb5c0
https://cris.maastrichtuniversity.nl/en/publications/86b3d207-4d0c-410e-9ba1-4cde75a7fe89
https://cris.maastrichtuniversity.nl/en/publications/86b3d207-4d0c-410e-9ba1-4cde75a7fe89
In this paper we examine the perceptions of entrepreneurs and other concerned individuals: which factors do they consider critical for success in the innovation process? From the perspective of the respondents, the entrepreneur is the most important
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______645::a71452dbc79e27d67d15d2f424395264
http://degree.ubvu.vu.nl/repec/vua/wpaper/pdf/20030001.pdf
http://degree.ubvu.vu.nl/repec/vua/wpaper/pdf/20030001.pdf
The informative value given by the announcement of distribution of dividend has already been investigated. One of the leading studies on this matter is Lintner (1956). Lintner found a relation between mutation in dividend, profits in the current fina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______645::c4e2a3ffe196dccb210374e881dbac7e
http://degree.ubvu.vu.nl/repec/vua/wpaper/pdf/19990020.pdf
http://degree.ubvu.vu.nl/repec/vua/wpaper/pdf/19990020.pdf